Fairfield Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-432
| Closed | -$79.7K | – | 96 |
|
|
2024
Q4 | $79.7K | Hold |
432
| – | – | 0.03% | 94 |
|
|
2024
Q3 | $85.1K | Sell |
432
-160
| -27% | -$31.5K | 0.03% | 106 |
|
|
2024
Q2 | $122K | Buy |
+592
| New | +$122K | 0.04% | 87 |
|
|
2023
Q4 | $278K | Sell |
1,177
-458
| -28% | -$108K | 0.11% | 63 |
|
|
2023
Q3 | $320K | Sell |
1,635
-145
| -8% | -$28.4K | 0.13% | 49 |
|
|
2023
Q2 | $374K | Sell |
1,780
-1,391
| -44% | -$292K | 0.15% | 50 |
|
|
2023
Q1 | $628K | Sell |
3,171
-610
| -16% | -$121K | 0.27% | 43 |
|
|
2022
Q4 | $824K | Sell |
3,781
-1,067
| -22% | -$232K | 0.38% | 34 |
|
|
2022
Q3 | $954K | Sell |
4,848
-1,162
| -19% | -$229K | 0.45% | 32 |
|
|
2022
Q2 | $1.29M | Sell |
6,010
-5,039
| -46% | -$1.08M | 0.59% | 29 |
|
|
2022
Q1 | $3.14M | Buy |
+11,049
| New | +$3.14M | 1.13% | 24 |
|